Literature DB >> 18156281

Association of circulating lactoferrin concentration and 2 nonsynonymous LTF gene polymorphisms with dyslipidemia in men depends on glucose-tolerance status.

José Maria Moreno-Navarrete1, Francisco José Ortega, Judit Bassols, Antoni Castro, Wifredo Ricart, José Manuel Fernández-Real.   

Abstract

BACKGROUND: Lactoferrin, an innate immune protein with antiinflammatory properties, shows considerable antiatherosclerosis activity in animal studies. We investigated the relationship between circulating lactoferrin, lactoferrin gene (LTF, lactotransferrin) polymorphisms, dyslipidemia, and vascular reactivity in the context of glucose-tolerance status in men.
METHODS: We evaluated 2 nonsynonymous LTF polymorphisms (rs1126477 and rs1126478) and measured circulating lactoferrin concentrations by ELISA under nonstressed conditions in healthy Caucasian men (n = 188) and male patients with an altered glucose tolerance (n = 202). We also studied the association of lactoferrin concentration with vascular reactivity via high-resolution ultrasound analysis of the brachial artery in a subsample of study participants.
RESULTS: Circulating lactoferrin concentration was inversely associated with fasting triglyceride concentration (r = -0.24; P = 0.001), body mass index (BMI) (r = -0.20; P = 0.007), waist-to-hip ratio (r = -0.35; P <0.001), and fasting glucose concentration (r = -0.18; P = 0.01), and directly correlated with HDL cholesterol concentration (r = 0.21; P = 0.004). Control AG heterozygotes for rs1126477 had significantly decreased fasting triglyceride concentrations (P = 0.001). Similarly, control individuals who were G carriers for rs1126478 had significantly lower fasting triglyceride concentrations (P = 0.044) and significantly higher HDL cholesterol concentrations (P = 0.028) than AA homozygotes. These associations remained significant after controlling for age, BMI, waist-to-hip ratio, fasting glucose concentration, smoking status, and alcohol intake. Circulating lactoferrin concentration was not significantly associated with endothelium-dependent vasodilatation (EDVD) in the individuals studied (n = 95); however, lactoferrin was positively associated with EDVD in obese participants with an altered glucose tolerance (r = 0.54; P = 0.04).
CONCLUSIONS: We have identified associations among LTF polymorphisms, circulating lactoferrin concentration, fasting triglyceride concentration, and vascular reactivity in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18156281     DOI: 10.1373/clinchem.2007.095943

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  22 in total

1.  Gene expression profiling and association of circulating lactoferrin level with obesity-related phenotypes in Latino youth.

Authors:  J Y Kim; L E Campbell; G Q Shaibi; D K Coletta
Journal:  Pediatr Obes       Date:  2014-11-14       Impact factor: 4.000

2.  Risk of nasopharyngeal carcinoma associated with polymorphic lactotransferrin haplotypes.

Authors:  Yanhong Zhou; Wei Wang; Danwei Zheng; Shuping Peng; Wei Xiong; Jian Ma; Zhaoyang Zeng; Minghua Wu; Ming Zhou; Juanjuan Xiang; Bo Xiang; Xiaoling Li; Xiayu Li; Guiyuan Li
Journal:  Med Oncol       Date:  2011-10-20       Impact factor: 3.064

3.  Analysis of new lactotransferrin gene variants in a case-control study related to periodontal disease in dog.

Authors:  Francisco Morinha; Carlos Albuquerque; João Requicha; Isabel Dias; José Leitão; Ivo Gut; Henrique Guedes-Pinto; Carlos Viegas; Estela Bastos
Journal:  Mol Biol Rep       Date:  2011-09-24       Impact factor: 2.316

4.  Expression levels of JNK associated with polymorphic lactotransferrin haplotypes in human nasopharyngeal carcinoma.

Authors:  Gengqiu Luo; Yanhong Zhou; Wei Yi; Hong Yi
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

5.  Targeting the association of calgranulin B (S100A9) with insulin resistance and type 2 diabetes.

Authors:  Francisco J Ortega; Josep M Mercader; José M Moreno-Navarrete; Mónica Sabater; Neus Pueyo; Sergio Valdés; Bartomeu Ruiz; Elodie Luche; Matteo Serino; Deborah Naon; Wifredo Ricart; Patricia Botas; Elias Delgado; Remy Burcelin; Gema Frühbeck; Fatima Bosch; Gertrude Mingrone; Antonio Zorzano; José M Fernández-Real
Journal:  J Mol Med (Berl)       Date:  2012-12-04       Impact factor: 4.599

6.  Human monocyte transcriptional profiling identifies IL-18 receptor accessory protein and lactoferrin as novel immune targets in hypertension.

Authors:  Matthew R Alexander; Allison E Norlander; Fernando Elijovich; Ravi V Atreya; Amadou Gaye; Juan S Gnecco; Cheryl L Laffer; Cristi L Galindo; Meena S Madhur
Journal:  Br J Pharmacol       Date:  2018-06-21       Impact factor: 8.739

7.  Cardiometabolic risk factors and lactoferrin: polymorphisms and plasma levels in French-Canadian children.

Authors:  Valérie Marcil; Sylvain Mayeur; Benoît Lamarche; Jade England; Mélanie Henderson; Edgard Delvin; Devendra Amre; Emile Levy
Journal:  Pediatr Res       Date:  2017-08-16       Impact factor: 3.756

8.  Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus.

Authors:  Sébastien Jacquemont; Alexandre Reymond; Flore Zufferey; Louise Harewood; Robin G Walters; Zoltán Kutalik; Danielle Martinet; Yiping Shen; Armand Valsesia; Noam D Beckmann; Gudmar Thorleifsson; Marco Belfiore; Sonia Bouquillon; Dominique Campion; Nicole de Leeuw; Bert B A de Vries; Tõnu Esko; Bridget A Fernandez; Fernando Fernández-Aranda; José Manuel Fernández-Real; Mònica Gratacòs; Audrey Guilmatre; Juliane Hoyer; Marjo-Riitta Jarvelin; R Frank Kooy; Ants Kurg; Cédric Le Caignec; Katrin Männik; Orah S Platt; Damien Sanlaville; Mieke M Van Haelst; Sergi Villatoro Gomez; Faida Walha; Bai-Lin Wu; Yongguo Yu; Azzedine Aboura; Marie-Claude Addor; Yves Alembik; Stylianos E Antonarakis; Benoît Arveiler; Magalie Barth; Nathalie Bednarek; Frédérique Béna; Sven Bergmann; Mylène Beri; Laura Bernardini; Bettina Blaumeiser; Dominique Bonneau; Armand Bottani; Odile Boute; Han G Brunner; Dorothée Cailley; Patrick Callier; Jean Chiesa; Jacqueline Chrast; Lachlan Coin; Charles Coutton; Jean-Marie Cuisset; Jean-Christophe Cuvellier; Albert David; Bénédicte de Freminville; Bruno Delobel; Marie-Ange Delrue; Bénédicte Demeer; Dominique Descamps; Gérard Didelot; Klaus Dieterich; Vittoria Disciglio; Martine Doco-Fenzy; Séverine Drunat; Bénédicte Duban-Bedu; Christèle Dubourg; Julia S El-Sayed Moustafa; Paul Elliott; Brigitte H W Faas; Laurence Faivre; Anne Faudet; Florence Fellmann; Alessandra Ferrarini; Richard Fisher; Elisabeth Flori; Lukas Forer; Dominique Gaillard; Marion Gerard; Christian Gieger; Stefania Gimelli; Giorgio Gimelli; Hans J Grabe; Agnès Guichet; Olivier Guillin; Anna-Liisa Hartikainen; Délphine Heron; Loyse Hippolyte; Muriel Holder; Georg Homuth; Bertrand Isidor; Sylvie Jaillard; Zdenek Jaros; Susana Jiménez-Murcia; Géraldine Joly Helas; Philippe Jonveaux; Satu Kaksonen; Boris Keren; Anita Kloss-Brandstätter; Nine V A M Knoers; David A Koolen; Peter M Kroisel; Florian Kronenberg; Audrey Labalme; Emilie Landais; Elisabetta Lapi; Valérie Layet; Solenn Legallic; Bruno Leheup; Barbara Leube; Suzanne Lewis; Josette Lucas; Kay D MacDermot; Pall Magnusson; Christian Marshall; Michèle Mathieu-Dramard; Mark I McCarthy; Thomas Meitinger; Maria Antonietta Mencarelli; Giuseppe Merla; Alexandre Moerman; Vincent Mooser; Fanny Morice-Picard; Mafalda Mucciolo; Matthias Nauck; Ndeye Coumba Ndiaye; Ann Nordgren; Laurent Pasquier; Florence Petit; Rolph Pfundt; Ghislaine Plessis; Evica Rajcan-Separovic; Gian Paolo Ramelli; Anita Rauch; Roberto Ravazzolo; Andre Reis; Alessandra Renieri; Cristobal Richart; Janina S Ried; Claudine Rieubland; Wendy Roberts; Katharina M Roetzer; Caroline Rooryck; Massimiliano Rossi; Evald Saemundsen; Véronique Satre; Claudia Schurmann; Engilbert Sigurdsson; Dimitri J Stavropoulos; Hreinn Stefansson; Carola Tengström; Unnur Thorsteinsdóttir; Francisco J Tinahones; Renaud Touraine; Louis Vallée; Ellen van Binsbergen; Nathalie Van der Aa; Catherine Vincent-Delorme; Sophie Visvikis-Siest; Peter Vollenweider; Henry Völzke; Anneke T Vulto-van Silfhout; Gérard Waeber; Carina Wallgren-Pettersson; Robert M Witwicki; Simon Zwolinksi; Joris Andrieux; Xavier Estivill; James F Gusella; Omar Gustafsson; Andres Metspalu; Stephen W Scherer; Kari Stefansson; Alexandra I F Blakemore; Jacques S Beckmann; Philippe Froguel
Journal:  Nature       Date:  2011-08-31       Impact factor: 49.962

Review 9.  Antimicrobial-sensing proteins in obesity and type 2 diabetes: the buffering efficiency hypothesis.

Authors:  José María Moreno-Navarrete; José Manuel Fernández-Real
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

10.  Common genetic variants of surfactant protein-D (SP-D) are associated with type 2 diabetes.

Authors:  Neus Pueyo; Francisco J Ortega; Josep M Mercader; José M Moreno-Navarrete; Monica Sabater; Sílvia Bonàs; Patricia Botas; Elías Delgado; Wifredo Ricart; María T Martinez-Larrad; Manuel Serrano-Ríos; David Torrents; José M Fernández-Real
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.